Insight, analysis & opinion from Joe Paduda

Jun
10

Why health reform will not be repealed

It’s pretty simple, really.
Once people gain actual real-life experience with a government program, they abandon their fear of the unknown, see its benefits more clearly, and become invested in its future.
We’ve seen that with Medicare, which consistently pleases its beneficiaries. Part D has similar traction, and now we’ve learned that the citizens of Massachusetts are increasingly happy with that state’s health reform.
I’m not arguing that Mass – or Part D or even Medicare itself are perfect, or anywhere close to that goal. That’s not the point of this post. The point is, the GOP’s continued abuse of anyone and anything remotely supportive of the ACA ignores history; once people experience a program, they like it – and more to the point, do NOT like politicians who threaten its existence.
A poll released by the Harvard’s School of Public Health and the Boston Globe indicates strong support for the state’s reform – 63% of residents polled supported the program, a jump of ten points from 2009; 21% – about one in five – oppose Mass’ reform.
The key here is the ten point increase in two years.
While major provisions of ACA will not be implemented for another two-and-a-half years, many have already seen a direct and personal impact. Dependents are covered till age 26. Lifetime maximum limits were eliminated. Kids with pre-existing conditions can now get coverage. Benefits for preventive care and screening have been greatly improved. Part D beneficiaries’ costs have been lowered and benefits improved. Some people previously uninsurable due to pre-existing conditions have obtained coverage.
When reform becomes broadly implemented – in thirty months – the premium subsidies for small employers kick in. Same for lower-income individuals and families. And the list goes on.
This is both a blessing and a curse. The more people know about a program, the better equipped they are to understand it and discuss it – and consider it when voting.
But, the more benefits they see, the harder it is for policy makers to convince voters the program needs to change. That’s where we are with Medicare, with Part D, with every entitlement program.
What does this mean for you?
Reform is here to stay.


Jun
9

Drug tests for everyone – Rick Scott goes off the deep end again

Our colleagues at Workers Comp Insider sent us news of Florida Governor Rick Scott’s latest idiocy – he issued an executive order requiring drug testing for all state employees every quarter.
The master of simple solutions to complex problems has done it again. Here’s a bit from Jon Coppelman’s piece.
“All current employees – regardless of what they do – must be randomly tested every quarter. Because drugs stay in the body for hours and even days after they are used, the governor is attempting to control every waking minute of the state workforce. Not even commercial drivers are subject to such stringent monitoring.
This policy does not stem from “business necessity” nor does it take into account individual freedom and the right to privacy. Using the governor’s logic, you could argue that everyone in America should, for one reason or another, be tested for illegal drugs. This is bad policy and, to put it bluntly, unAmerican.”
A few questions spring to mind.
– does this include Scott and his staff, and all political appointees? the language seems to say it does.
– is this Constitutional ? seems like a potential case could be made that this is a violation of due process, privacy…
– what are the legal implications? Scott’s Order will result in hundreds of thousands of drug tests each year – many will be false positives, leading to…what? what is the next step? retest? what recourse will workers have if their tests are positive? do they get fired immediately? what if they metabolize meds differently?
the drug tests are for ‘illegal drugs’ only, yet the abuse of prescription drugs has surpassed illegal drugs on the popularity scale. So, what does Scott’s Order do about rampant abuse of opioids in Florida? anything?
– how much is this going to cost? let’s see…
168,000 state employees.
tested 4 times each year
figuring a drug test (all in, staffing, reporting, actual test, etc) costs about $100 (they’re much more expensive on a retail basis, but Scott will likely go for a low bid.
and the total is – $67,000,000.
Yep, $67 million dollars.
and this from the idiot who didn’t want to implement a Prescription Drug Monitoring Program because it would cost less than a million dollars a year.
Now, let’s add in the legal costs – because employees will sue if they get fired. And the cost of hiring replacement workers (who all have to get drug screens).
and remember this doesn’t address abuse of OxyContin etc.
What does this mean for you?
next time you vote, consider the consequences.


Jun
6

The major changes in Illinois’ workers compensation system are stirring much conversation, modeling, and debate among stakeholders. One of the least-understood (at least by me) provisions of the reform legislation dealt with the adoption of impairment guidelines.
The person who probably knows more about impairment and disability assessment than anyone else alive was kind enough to offer his thoughts on the issue. Chris Brigham, MD, has been involved in this issue for thirty years. Here are his thoughts on the potential impact of the guidelines in Illinois:
In the past determining permanent partial disability was not consistent in the State of Illinois since the Industrial Commission did not make use of any standard guidelines, such as the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), which are used in the vast majority of state workers’ compensation systems in the United States, in other arenas, and internationally. Historically, the Industrial Commission would determine the extent of PPD (Permanent Partial Disability) based on their “experience” and would not allow testimony for any doctor’s opinion as to the percent of disability. Factors that the Commission considered (and will continue to consider until 9/1/2011) are nature of accident and injury, extent of lost time, physical findings, ability to return to work, description of job, average weekly wage, and subjective complaints. Adding the use of the Guides as a component in determining PPD awards has the potential of increasing the reliability and consistency of these awards.
House Bill 1698, Section 8.1b Determination of permanent partial disability, applies to injuries that occur on or after September 1, 2011. Since permanent impairment is not assessed until the claimant has achieved maximal medical improvement (MMI), which may not occur until a year or longer post injury if there is permanent loss, it is probable that this will not significantly impact actual claims until mid 2012. However stakeholders need to be prepared for this change.
The most current edition of the AMA Guides is the Sixth Edition, which reflects substantial improvement in impairment assessment. The Sixth Edition is currently used by fourteen states, for Federal Employee’s Compensation Act (FECA) cases, and internationally by several countries.The assessments must be performed by physicians; this is consistent with the standards defined in the AMA Guides and makes sense since clinical judgment is required by the Sixth Edition. Based on our experience nationally reviewing several thousand ratings, there is a relatively high error rate in assessing impairment; therefore, steps will need to be taken to assure accuracy.
I asked Chris to expand on the issue of errors in determining ratings and impairment; here’s his response.
We are observing a lower error rate with the Sixth Edition [compared to the Fifth Edition] which reflects significant improvement in the process of assessing impairment, using a more contemporary and consistent methodology – one that is less likely to result in errors.
Several steps should be taken to reduce the error rate, starting by recognition of the significance of this problem. This has been area that the property and casualty field has not adequately addressed, resulting in significant costs – both financial and personal (having some perceive themselves as more impaired than they actually are).
– Impairment ratings must be done when the individual is at maximal medical improvement; therefore clients should take steps to determine if someone is at MMI and then proactive steps to assure an accurate rating.
– The process of assessing impairment is based primarily on three steps: 1) obtaining clinical data (history, physical examination findings, and studies), 2) analysis of the clinical data and 3) applying the data to the criteria provided in the Guides (consistent with specific procedures as defined in the Guides). The traditional rating process has the same person (the physician, either treating or IME) perform all three steps; however this does not work well.
– Ratings should be performed by skilled IME physicians who have demonstrated competency in performing ratings and the quality of their work should be monitored. In advance, clients can have experts on the Guides review the clinical data (obtained from step 1, typically this information is available in clinical records), analyze this data, and either prepare a rating for review by an evaluating physician or provide guidance on how the rating should be done.
– All impairment ratings received should be “screened” based on certain criteria, and if impairment ratings are above a specific threshold or “red flags” are identified, the ratings should be involved by experts on the Guides. We find that this is a highly technical area requiring both significant experience with the Guides and working closely with physicians; we find that this typically is not within the skill set of an adjuster or attorney. If the expert finds the rating to be incorrect, than interventions should be taken to correct the rating. These interventions are dependent on the jurisdiction and case.
– We have developed an approach that works well in securing an accurate rating; this process involves assigning the three step process to two different parties, with the steps 1 and 2 being carried out by an evaluating physician (an IME physician following specific directives about what data to provide) and, using the resulting data, have step 3 completed by an expert on the rating process. This is similar to the process many of us use for our taxes, e.g. we are given directives about what data to obtain and this data is then reviewed by another party to complete the forms and compute the final result.
The Sixth Edition, the current Edition, will be used in Illinois, and this should be of tremendous benefit in achieving more reliable ratings. In the Fifth Edition there are differing approaches depending on which chapter is used, however in the Sixth Edition the approaches are consistent reflecting methodology used with the International Classification of Functioning, Disability and Health.
The impairment rating is only one factor that will be considered in determining the level of permanent partial disability. Other factors that must be considered: the occupation of the injured employee; the age of the employee at the time of the injury; the employee’s future earning capacity; and evidence of disability corroborated by the treating medical records. No single factor shall be the sole determinant of disability.
Since impairment is not synonymous with disability, it is appropriate to consider other factors in determining disability. The amendment states “In determining the level of disability, the relevance and weight of any factors used in addition to the level of impairment as reported by the physician must be explained in a written order.” The fact finder will need to use judgment; however the rationale for the decision must be documented. Significant weight should be given to the impairment rating in determining the PPD.
Chris’ conclusion – To have the impact the House Bill was meant to have, we recommend the arbitrators give thoughtful consideration to the AMA Guides rating and how it was determined. It they do, we believe this process will result in both a more valid and reliable process to determine permanent partial disability. If they do not, the improvement hoped for will not be achieved. Requiring use of the current edition of the AMA Guides is a positive step forward in assuring more appropriate permanent partial disability awards.
What does this mean for you?
While the new Impairment Rating methodology has promise, the actual impact depends just as much on HOW the methodology is implemented as the tools used. This is not a panacea, nor is it a purposeful attempt to harm workers. One hopes the parties will work together to make sure the implementation is effective and well-designed.
One hopes.


Jun
2

Work comp reform in Illinois – the details

With the passage of major work comp reform in Illinois, there’s lots of interest in determining exactly what was passed, and more importantly what it means.
First, the bill. It’s not easy to find it, as it is ‘hidden’ on the Illinois state site; when you click on the link for HB 1698 it brings up a bill addressing adoption; I have no idea why, probably due to parliamentary procedure requirements dealing with bill introduction.
The bill you’re looking for is here.
There are several provisions that address key issues.
Tightening awards for carpal tunnel – this had to be in there. A report by the Belleville News-Democrat on a ‘pandemic’ of carpal tunnel claims filed by guards at a downstate prison incited outrage across the state. According to the story, “taxpayers paid almost $10 million to employees at Menard [the prison] for various workers’ compensation injuries. In all, more than 500 claims were filed, and about half are pending.”
Utilization review – while UR has been around for years in IL, it’s been a pretty toothless UR. The new provisions put the onus on the worker to show why their treatment is appropriate if the payer finds it does not meet criteria for medical necessity.
Fee schedule reduction – the biggie. While there’s so much spin around this from providers it’s a wonder Illinois hasn’t disappeared into a vortex, there’s no getting around this – its a major reduction in provider reimbursement. Yes, their fees will still be among the highest in the country, but a thirty percent reduction is meaningful. There’s a bit of confusion about the basis for the fee schedule; currently it is based on 90 percent of Ingenix’ 80th percentile, split up into 29 geographic areas. There’s an annual inflation rate increase pegged to the CPI.
Provider networks – the ‘Preferred Provider Program’ – yes, this brings employer direction to Illinois work comp. Well, sorta. Here are some of the details (there’s lots to digest, so this is going to take some time).
– the State Department of Insurance has to certify Preferred Provider Programs – there’s too much text to quote here – search for “Sec. 8.1a. Preferred provider programs” – relevant section starts on page 88 line 23.
– when an employee reports an injury the employer has to tell him/her of the PPP and the employee’s need to choose a physician from the PPP.
– employees can opt out of the PPP – here’s the relevant text:

“Subsequent to the report of an injury by an employee, the employee may choose in writing at any time to decline the preferred provider program, [emphasis added] in which case that would constitute one of the two choices of medical providers to which the employee is entitled under subsection (a)(2) or (a)(3)”

Essentially this allows the injured worker to choose their initial treating doc, who controls their referrals to specialists, ancillary providers, and facilities. My take on the network direction provision is it is pretty weak, and – realistically – will help with those claimants engaged in doctor shopping. However, payers’ ability to control which physicians and other providers treat their injured worker, while certainly strengthened, is not greatly enhanced.
There’s a lot more to this, and undoubtedly more to be determined through the regulatory process as well. I leave discussion of impairment ratings, disability determination, and other key provisions to those more expert than I.
What does this mean to you?
For employers, and most employees, and certainly taxpayers – this is long awaited and pretty good news. Costs will come down. Doctor shopping, while not fixed, will be more visible and better monitored. Providers will have to show payers and employers they are serious about treating with a focus on return to work.
And premiums, and the burden on Illinois’ taxpayers, will come down too.


Jun
1

Illinois work comp reform – the impossible is reality

Late last night the Illinois House passed major work comp reform legislation, legislation that will dramatically affect workers’ comp providers, significantly reduce medical cost, and tighten up several key issues related to claim duration.
While most are focusing on the 30% reduction to the fee schedule (currently set at 80% of the 90th percentile of Ingenix’ UCR), the major change will likely be the institution of employer direction in a state long tied to employee freedom of choice. The bill – HB1698 – allows employers to use medical networks that are approved by the state Department of Insurance, a change that will dramatically alter the provider landscape, greatly strengthening networks’ ability to contract at rates lower than the fee schedule. While the new law will allow employees to opt out of the network at the time of injury, they have to do so in writing.
Governor Pat Quinn will sign the legislation, which also passed the Senate – this time easily.
More news is here.
A synopsis of some of the main provisions is here. (note this appears to be a plaintiff attorney’s interpretation)


May
31

Sedgwick buys Xchanging

The Brits finally threw in the towel. After several years of working diligently to make a go of the US TPA market, Xchanging cut its losses, selling what used to be known as Cambridge Integrated Services to Sedgwick for a price rumored to be in the low tens of millions.
Cambridge had been on a slow but steady downward spiral for some time, losing clients, adjusting talent, and revenues and failing to land much, if any new business. According to folks who had worked there, there was a good-faith effort on the part of Xchanging to reshape Cambridge’s adjusting process into a more…Continental model, including changing workspaces to open tables. This didn’t go over so well, helping to add to the talent loss.
With this latest deal, Sedgwick further elevates itself above the rest of the TPA pack. Notably, the deal includes a settlement services entity, yet another vendor Sedgwick will add to its portfolio. It also removes a potential competitor, although as noted above, Cambridge wasn’t too much of a threat of late.
Here’s hoping the folks left behind at Cambridge find the transition a good one, and their futures brighter than they were yesterday.


May
31

Drug testing in workers comp – we need more, not less.

In the online edition of Risk and Insurance, fellow work comp consultant Maddy Bowling authored a piece focused on a rapidly growing segment of the work comp managed care industry – drug testing. Maddy’s a very experienced, and very knowledgeable work comp professional, and I completely agree with her main point – payers would do well to make sure they “connect the dots”.
That said, I have a somewhat different take re drug testing’s purpose and value.
To be clear, I’m referring to the use of urine screening for claimants prescribed narcotic opioids – the Schedule II drugs that are potentially addictive, at risk for diversion, often quite expensive, and not indicated for long-term use for musculo-skeletal ailments. (I’m NOT referring to pre-employment screening or testing post-accident.)
Maddy asks some highly relevant questions:
“aren’t our pharmacy benefit management (PBM) vendors identifying multiple prescribers, multiple prescriptions and potential drug interactions? Aren’t they identifying cases that require detailed drug reviews and possible peer intervention? Aren’t they identifying the top opioid prescribers in your book of business? Isn’t your PBM reviewing your out-of-network pharmacy bills to ensure that they have all the pharmacy information on every injured worker and taking action if anything seems inappropriate?”
All these are important, necessary, and should be part of your pharmacy management program.
But PBMs can’t do everything on their own, and neither can case managers. Maddy observes that on-site case managers can check bottles to see if drugs are being taken, ask about non-prescribed (illicit) drug seeking behavior, and ask the claimant specific questions about compliance. While I respect the ability of many field case managers, it is unlikely they will be able to consistently and accurately discriminate between truthful and less-than-truthful claimants.
Drug testing can provide quantitative evidence of compliance with drug treatment plans. It can also:
– identify illicit drugs in the claimant’s urine (thereby providing evidence of compliance with opioid agreements)
– identify claimants with genetic tendencies to rapidly (or otherwise ‘differently’ metabolize opioids (this from the Mayo Clinic “To optimize treatment for individual patients, clinicians must understand the variability in the ways different opioids are metabolized and be able to recognize the patient characteristics likely to influence opioid metabolism.”
Drug testing is also relatively cheap. We’re talking a few hundred dollars per test;
– equivalent to a few hours of case management,
– a relative bargain when compared to the cost of a couple months of OxyContin and many other opioids,
– and a screaming deal when compared to extended indemnity benefits, settlement costs, and MSAs.
I’m pretty familiar with the monitoring, alert, and management tools in the PBMs’ and payers’ armamentarium. And there’s no question most payers would do well to utilize more of those tools, to, in Maddy’s words, help ‘connect the dots’.
I’m also quite sure there’s far too little use of drug testing in workers comp.
It’s not just me. The State of Washington adopted strict guidelines for opioid prescribing (opens google doc), guidelines that include provisions for urine drug testing.
What does this mean for you?
The overuse and abuse of opioids in workers comp is a disaster – economically, financially, and socially. There’s also no question some individuals metabolize opioids differently. Drug testing can help physicians – and patients – better manage pain, while adding a level of certainty that subjective opinion…can’t.


May
27

Peter Rousmaniere’s piece in Risk and Insurance outlines precisely what needs to be done to reduce unnecessary medical costs in comp.
To date, most ‘managed care’ programs have had little real impact; most just shift costs around and develop phantom savings so sponsors can show what a great job they are doing by cutting reimbursement – oftentimes on bills for services that shouldn’t have been delivered in the first place.
The focus should be on:
– data data data – making sure it is high quality and consistent, and then using that data to develop a deep understanding of cost drivers and how they are evolving.
– managing chronic pain, opioids and addiction to same
– aggressively directing injured workers to excellent providers and paying them whatever it takes to get their attention and cooperation.

Of course, you can always just continue to do what you’re doing today…


May
26

HWR is up at Health Affairs

Our colleagues at Health Affairs have the honor of hosting this edition of HWR. Lots of great insights into the Medicare Trustees report, the growing body of work explaining the impact of health reform, and what states and employers are doing to control costs and improve quality.


May
26

Politicians’ amazingly poor memory

The expansion of Medicare to include coverage for prescription drugs was a political masterstroke. In a single move, the GOP won the hearts and votes of seniors. The result was significant – larger Republican majorities in Congress, and re-election for George Bush. (I know, there were a few other issues and a poor candidate at the top of the ticket for the Dems)
That was less than a decade ago.
Now, the GOP has decided on a policy of self-immolation. Paul Ryan’s Medicare plan likely cost the GOP a previously safe seat in upstate New York, has led several Republican Senators to vote against the plan, and resulted in erstwhile Presidential contender Newt Gingrich alternately slamming and praising Ryan and his plan.
While GOP loyalists will argue that Ryan’s plan is meant to save Medicare, that assertion is false on its face. In reality, it transfers the risk to seniors, a risk that Medicare assumed when it become law in 1964. One can argue as to whether or how much risk seniors should assume; one cannot argue that the Ryan plan will save Medicare.
But that’s beside the point.
What Ryan et al forgot was that seniors guard Medicare like momma bears guard their cubs. I find it bizarre that the same party that single-handedly passed Medicare Part D in an effort to win this crucial voting block has pulled a 180.
Part D worked to keep the GOP in power. Ryan’s plan may well have the opposite effect.
In fact, this may be worse. Tea partiers – well, at least some folks who seem to share the same agenda – are mad that the GOP passed Part D, seeing it as an unaffordable expansion of Federal entitlement programs (I agree). So, there’s a ‘base alienation’ issue here as well as a senior vote alienation problem.
Ouch.
For more on this, see Bob Laszewski’s excellent piece.


Joe Paduda is the principal of Health Strategy Associates

SUBSCRIBE BY EMAIL

SEARCH THIS SITE

A national consulting firm specializing in managed care for workers’ compensation, group health and auto, and health care cost containment. We serve insurers, employers and health care providers.

 

DISCLAIMER

© Joe Paduda 2025. We encourage links to any material on this page. Fair use excerpts of material written by Joe Paduda may be used with attribution to Joe Paduda, Managed Care Matters.

Note: Some material on this page may be excerpted from other sources. In such cases, copyright is retained by the respective authors of those sources.

ARCHIVES

Archives